Bone Void Articles & Analysis
7 news found
Effective July 1st, the new agreement allows Premier members, at their discretion, to take advantage of pricing and terms pre-negotiated by Premier for CERAMENT® BONE VOID FILLER. “The awarded contract by Premier is a strong testimony and confirmation of the unique value CERAMENT offers hospitals, surgeons and patients. This agreement will further ...
Currently, the standard treatment for chronic osteomyelitis is surgical debridement, long-term, high-dose administration of antibiotics, and – for larger defects – bone grafting which often requires a second surgical procedure to remove the non-resorbable bone graft. CognitOss is intended to offer surgeons a single surgical procedure alternative, ...
GRAFTYS SA (“Graftys”), a global leader in resorbable bone cements, is proud to announce that as a fruitful result of 10 years’ partnership with its distributor - LAS Brasil, the milestone of 10,000 units of GRAFTYS® HBS sold in Brazil has been crossed during the third quarter of 2020. GRAFTYS® HBS is a calcium phosphate bone graft substitute, which offers very low ...
ByGraftys
The contract will enable NuShores to develop intelligent automated production of its NuCress™ bone void filler scaffold products using its “factory in a box” concept. ...
GRAFTYS SA (“Graftys”), a global leader in resorbable bone cements, is pleased to announce the CE recertification in Europe and the certification of its Quality Management System in conformity with the Medical Device Single Audit Program (MDSAP) in Australia, Brazil, Canada and the United States of America for the Design, Manufacture and Distribution of its Sterile ...
ByGraftys
He will lead NuShores Generation 1 manufacturing of NuCress™ bone void filler scaffold products and serve as the Program Director and Principal Investigator on new and pending manufacturing projects to automate the company’s production systems. ...
Various types of bone graft substitutes such as collagen, demineralized bone matrix, xenograft, artificial bone, and growth factor products are available, but none of these products are more effective than the gold-standard, autologous bone graft. ...